back to cluster viewer
cluster path 111110100
227 words, 134,675 tokens
freq alpha suffix
Words in frequency order
1 | 1 | 133,836
|
2 | 1/4 | 152
|
3 | edic | 66
|
4 | ~1 | 58
|
5 | ±1 | 39
|
6 | 1:1000 | 30
|
7 | t20 | 25
|
8 | 1l | 23
|
9 | 003 | 13
|
10 | 12d | 13
|
11 | ≈1 | 13
|
12 | 200ml | 10
|
13 | 60/100 | 8
|
14 | hike | 8
|
15 | 1minute | 7
|
16 | ≥114 | 7
|
17 | 6-halts | 6
|
18 | 800mg/day | 6
|
19 | ln1 | 6
|
20 | m2-124 | 6
|
21 | e70 | 5
|
22 | r18 | 5
|
23 | r2-m | 5
|
24 | -0.205 | 4
|
25 | -2d | 4
|
26 | 0.5mg/kg/day | 4
|
27 | 2.4-4.8 | 4
|
28 | 20050203 | 4
|
29 | 3587 | 4
|
30 | fbtp | 4
|
31 | it-m | 4
|
32 | pio-mono | 4
|
33 | sevo1.8 | 4
|
34 | 0.5μm | 3
|
35 | 0.90-0.96 | 3
|
36 | 0·725 | 3
|
37 | 1/24 | 3
|
38 | 210th | 3
|
39 | 2–4 | 3
|
40 | 34±14 | 3
|
41 | 4.0-5.5 | 3
|
42 | 4.8-5.1 | 3
|
43 | 48-weeks | 3
|
44 | 50-60°c | 3
|
45 | 7-par | 3
|
46 | a-5 | 3
|
47 | al-i | 3
|
48 | ecj | 3
|
49 | g1359a | 3
|
50 | hardjo-bovis | 3
|
51 | l15 | 3
|
52 | leone® | 3
|
53 | p=0.258 | 3
|
54 | pcup3 | 3
|
55 | pi-treatment | 3
|
56 | rcwmch | 3
|
57 | va- | 3
|
58 | /=0.2 | 2
|
59 | 0.11±0.008 | 2
|
60 | 1-3min | 2
|
61 | 14-60 | 2
|
62 | 16-years | 2
|
63 | 1979-1987 | 2
|
64 | 1981-1998 | 2
|
65 | 1988-1996 | 2
|
66 | 2.0±1.8 | 2
|
67 | 2.4±0.8 | 2
|
68 | 2.9~6.2 | 2
|
69 | 205.9 | 2
|
70 | 20:1000 | 2
|
71 | 2500g- | 2
|
72 | 27,418 | 2
|
73 | 2=1 | 2
|
74 | 4.3/1000 | 2
|
75 | 4.5±1.9 | 2
|
76 | 40-tx | 2
|
77 | 400iu | 2
|
78 | 5.5days | 2
|
79 | 51.00 | 2
|
80 | 58.28 | 2
|
81 | 6/479 | 2
|
82 | 60-600 | 2
|
83 | 7-1 | 2
|
84 | 7157 | 2
|
85 | 73-83 | 2
|
86 | 8-75 | 2
|
87 | 9.5/1000 | 2
|
88 | a-75 | 2
|
89 | bbop | 2
|
90 | ca-cdi | 2
|
91 | caesalpinioideae | 2
|
92 | cals8 | 2
|
93 | cr-3 | 2
|
94 | dansyl-sstsaa-w | 2
|
95 | dapis | 2
|
96 | days-1 | 2
|
97 | dcbe | 2
|
98 | gbp2 | 2
|
99 | ri-7 | 2
|
100 | rm-2 | 2
|
101 | school-entrance | 2
|
102 | vicr | 2
|
103 | βmaks | 2
|
104 | +/-0,64 | 1
|
105 | -1.91+/-0.36 | 1
|
106 | -10.319 | 1
|
107 | /=4th | 1
|
108 | 0.237×gestational | 1
|
109 | 0.38-0.45 | 1
|
110 | 0.55-0.63 | 1
|
111 | 0=ovulation | 1
|
112 | 0=treatment | 1
|
113 | 1'c | 1
|
114 | 1.6/restricted | 1
|
115 | 1/8th | 1
|
116 | 106,6 | 1
|
117 | 11,2013 | 1
|
118 | 117+/-3 | 1
|
119 | 11th-14th | 1
|
120 | 11u/l | 1
|
121 | 12-th | 1
|
122 | 12.7±4 | 1
|
123 | 13.3/1000 | 1
|
124 | 130-145 | 1
|
125 | 15. | 1
|
126 | 161-167 | 1
|
127 | 166/91 | 1
|
128 | 171±116 | 1
|
129 | 1966-3rd | 1
|
130 | 19th-24th | 1
|
131 | 1:82.4 | 1
|
132 | 1=1 | 1
|
133 | 1=92 | 1
|
134 | 1a=201 | 1
|
135 | 1tss | 1
|
136 | 2-1-5-3 | 1
|
137 | 2056.8 | 1
|
138 | 22±2.1 | 1
|
139 | 261+/-36 | 1
|
140 | 266+/-25 | 1
|
141 | 29-90 | 1
|
142 | 2=91 | 1
|
143 | 3-83.5 | 1
|
144 | 3-tx | 1
|
145 | 3.5-3.2 | 1
|
146 | 3.5/1000 | 1
|
147 | 3.5±3.2 | 1
|
148 | 30-day,6-12 | 1
|
149 | 32,3 | 1
|
150 | 361.5±8.2 | 1
|
151 | 37.3±4.9 | 1
|
152 | 3:22 | 1
|
153 | 3x/day-1 | 1
|
154 | 3x12 | 1
|
155 | 4.6±18.1 | 1
|
156 | 44,1 | 1
|
157 | 45,1 | 1
|
158 | 45.96 | 1
|
159 | 48,946 | 1
|
160 | 4:17 | 1
|
161 | 5-747 | 1
|
162 | 5/vs | 1
|
163 | 50.01-100 | 1
|
164 | 51.31±15.80 | 1
|
165 | 53.83±6.57 | 1
|
166 | 6.2-10.9 | 1
|
167 | 67,1 | 1
|
168 | 7,33 | 1
|
169 | 7788/18 | 1
|
170 | 8.6-10.9 | 1
|
171 | 8025 | 1
|
172 | 87.6-100 | 1
|
173 | 9,6 | 1
|
174 | 9,8 | 1
|
175 | 91.4+/-21.9 | 1
|
176 | 93-1,140 | 1
|
177 | 94+/-10 | 1
|
178 | 99.5-100 | 1
|
179 | a,15 | 1
|
180 | a-1.23 | 1
|
181 | a-35 | 1
|
182 | a-85.2 | 1
|
183 | a=6 | 1
|
184 | a=68.9 | 1
|
185 | adm/bdm | 1
|
186 | age=23.7±5.5 | 1
|
187 | age≥1 | 1
|
188 | and∼65 | 1
|
189 | assessment- | 1
|
190 | b-87.1 | 1
|
191 | b=6 | 1
|
192 | b=66.51 | 1
|
193 | baseline-12 | 1
|
194 | breaks/sedentary | 1
|
195 | c-75.4 | 1
|
196 | c=10 | 1
|
197 | compliance=71 | 1
|
198 | cost-assumption | 1
|
199 | cpr1 | 1
|
200 | d-35 | 1
|
201 | difference=8.7 | 1
|
202 | drug-11.2 | 1
|
203 | eur/life | 1
|
204 | five/six | 1
|
205 | gpc5 | 1
|
206 | ii-20:20 | 1
|
207 | ii-insufficiency | 1
|
208 | iii-2 | 1
|
209 | iii-30:10 | 1
|
210 | inditherm | 1
|
211 | invasiva | 1
|
212 | iv-75.3 | 1
|
213 | iv-84.9 | 1
|
214 | k=9.4 | 1
|
215 | micerium® | 1
|
216 | microl/100 | 1
|
217 | month-test | 1
|
218 | myrenne | 1
|
219 | pdi/bpdrf | 1
|
220 | pubs-positive | 1
|
221 | querco | 1
|
222 | r-china | 1
|
223 | reclinata | 1
|
224 | terricola | 1
|
225 | two-four | 1
|
226 | tyrrell | 1
|
227 | ≤half | 1
|
Words in alphabetical order
1 | +/-0,64 | 1
|
2 | -0.205 | 4
|
3 | -1.91+/-0.36 | 1
|
4 | -10.319 | 1
|
5 | -2d | 4
|
6 | /=0.2 | 2
|
7 | /=4th | 1
|
8 | 0.11±0.008 | 2
|
9 | 0.237×gestational | 1
|
10 | 0.38-0.45 | 1
|
11 | 0.55-0.63 | 1
|
12 | 0.5mg/kg/day | 4
|
13 | 0.5μm | 3
|
14 | 0.90-0.96 | 3
|
15 | 003 | 13
|
16 | 0=ovulation | 1
|
17 | 0=treatment | 1
|
18 | 0·725 | 3
|
19 | 1 | 133,836
|
20 | 1'c | 1
|
21 | 1-3min | 2
|
22 | 1.6/restricted | 1
|
23 | 1/24 | 3
|
24 | 1/4 | 152
|
25 | 1/8th | 1
|
26 | 106,6 | 1
|
27 | 11,2013 | 1
|
28 | 117+/-3 | 1
|
29 | 11th-14th | 1
|
30 | 11u/l | 1
|
31 | 12-th | 1
|
32 | 12.7±4 | 1
|
33 | 12d | 13
|
34 | 13.3/1000 | 1
|
35 | 130-145 | 1
|
36 | 14-60 | 2
|
37 | 15. | 1
|
38 | 16-years | 2
|
39 | 161-167 | 1
|
40 | 166/91 | 1
|
41 | 171±116 | 1
|
42 | 1966-3rd | 1
|
43 | 1979-1987 | 2
|
44 | 1981-1998 | 2
|
45 | 1988-1996 | 2
|
46 | 19th-24th | 1
|
47 | 1:1000 | 30
|
48 | 1:82.4 | 1
|
49 | 1=1 | 1
|
50 | 1=92 | 1
|
51 | 1a=201 | 1
|
52 | 1l | 23
|
53 | 1minute | 7
|
54 | 1tss | 1
|
55 | 2-1-5-3 | 1
|
56 | 2.0±1.8 | 2
|
57 | 2.4-4.8 | 4
|
58 | 2.4±0.8 | 2
|
59 | 2.9~6.2 | 2
|
60 | 20050203 | 4
|
61 | 200ml | 10
|
62 | 205.9 | 2
|
63 | 2056.8 | 1
|
64 | 20:1000 | 2
|
65 | 210th | 3
|
66 | 22±2.1 | 1
|
67 | 2500g- | 2
|
68 | 261+/-36 | 1
|
69 | 266+/-25 | 1
|
70 | 27,418 | 2
|
71 | 29-90 | 1
|
72 | 2=1 | 2
|
73 | 2=91 | 1
|
74 | 2–4 | 3
|
75 | 3-83.5 | 1
|
76 | 3-tx | 1
|
77 | 3.5-3.2 | 1
|
78 | 3.5/1000 | 1
|
79 | 3.5±3.2 | 1
|
80 | 30-day,6-12 | 1
|
81 | 32,3 | 1
|
82 | 34±14 | 3
|
83 | 3587 | 4
|
84 | 361.5±8.2 | 1
|
85 | 37.3±4.9 | 1
|
86 | 3:22 | 1
|
87 | 3x/day-1 | 1
|
88 | 3x12 | 1
|
89 | 4.0-5.5 | 3
|
90 | 4.3/1000 | 2
|
91 | 4.5±1.9 | 2
|
92 | 4.6±18.1 | 1
|
93 | 4.8-5.1 | 3
|
94 | 40-tx | 2
|
95 | 400iu | 2
|
96 | 44,1 | 1
|
97 | 45,1 | 1
|
98 | 45.96 | 1
|
99 | 48,946 | 1
|
100 | 48-weeks | 3
|
101 | 4:17 | 1
|
102 | 5-747 | 1
|
103 | 5.5days | 2
|
104 | 5/vs | 1
|
105 | 50-60°c | 3
|
106 | 50.01-100 | 1
|
107 | 51.00 | 2
|
108 | 51.31±15.80 | 1
|
109 | 53.83±6.57 | 1
|
110 | 58.28 | 2
|
111 | 6-halts | 6
|
112 | 6.2-10.9 | 1
|
113 | 6/479 | 2
|
114 | 60-600 | 2
|
115 | 60/100 | 8
|
116 | 67,1 | 1
|
117 | 7,33 | 1
|
118 | 7-1 | 2
|
119 | 7-par | 3
|
120 | 7157 | 2
|
121 | 73-83 | 2
|
122 | 7788/18 | 1
|
123 | 8-75 | 2
|
124 | 8.6-10.9 | 1
|
125 | 800mg/day | 6
|
126 | 8025 | 1
|
127 | 87.6-100 | 1
|
128 | 9,6 | 1
|
129 | 9,8 | 1
|
130 | 9.5/1000 | 2
|
131 | 91.4+/-21.9 | 1
|
132 | 93-1,140 | 1
|
133 | 94+/-10 | 1
|
134 | 99.5-100 | 1
|
135 | a,15 | 1
|
136 | a-1.23 | 1
|
137 | a-35 | 1
|
138 | a-5 | 3
|
139 | a-75 | 2
|
140 | a-85.2 | 1
|
141 | a=6 | 1
|
142 | a=68.9 | 1
|
143 | adm/bdm | 1
|
144 | age=23.7±5.5 | 1
|
145 | age≥1 | 1
|
146 | al-i | 3
|
147 | and∼65 | 1
|
148 | assessment- | 1
|
149 | b-87.1 | 1
|
150 | b=6 | 1
|
151 | b=66.51 | 1
|
152 | baseline-12 | 1
|
153 | bbop | 2
|
154 | breaks/sedentary | 1
|
155 | c-75.4 | 1
|
156 | c=10 | 1
|
157 | ca-cdi | 2
|
158 | caesalpinioideae | 2
|
159 | cals8 | 2
|
160 | compliance=71 | 1
|
161 | cost-assumption | 1
|
162 | cpr1 | 1
|
163 | cr-3 | 2
|
164 | d-35 | 1
|
165 | dansyl-sstsaa-w | 2
|
166 | dapis | 2
|
167 | days-1 | 2
|
168 | dcbe | 2
|
169 | difference=8.7 | 1
|
170 | drug-11.2 | 1
|
171 | e70 | 5
|
172 | ecj | 3
|
173 | edic | 66
|
174 | eur/life | 1
|
175 | fbtp | 4
|
176 | five/six | 1
|
177 | g1359a | 3
|
178 | gbp2 | 2
|
179 | gpc5 | 1
|
180 | hardjo-bovis | 3
|
181 | hike | 8
|
182 | ii-20:20 | 1
|
183 | ii-insufficiency | 1
|
184 | iii-2 | 1
|
185 | iii-30:10 | 1
|
186 | inditherm | 1
|
187 | invasiva | 1
|
188 | it-m | 4
|
189 | iv-75.3 | 1
|
190 | iv-84.9 | 1
|
191 | k=9.4 | 1
|
192 | l15 | 3
|
193 | leone® | 3
|
194 | ln1 | 6
|
195 | m2-124 | 6
|
196 | micerium® | 1
|
197 | microl/100 | 1
|
198 | month-test | 1
|
199 | myrenne | 1
|
200 | p=0.258 | 3
|
201 | pcup3 | 3
|
202 | pdi/bpdrf | 1
|
203 | pi-treatment | 3
|
204 | pio-mono | 4
|
205 | pubs-positive | 1
|
206 | querco | 1
|
207 | r-china | 1
|
208 | r18 | 5
|
209 | r2-m | 5
|
210 | rcwmch | 3
|
211 | reclinata | 1
|
212 | ri-7 | 2
|
213 | rm-2 | 2
|
214 | school-entrance | 2
|
215 | sevo1.8 | 4
|
216 | t20 | 25
|
217 | terricola | 1
|
218 | two-four | 1
|
219 | tyrrell | 1
|
220 | va- | 3
|
221 | vicr | 2
|
222 | ~1 | 58
|
223 | ±1 | 39
|
224 | βmaks | 2
|
225 | ≈1 | 13
|
226 | ≤half | 1
|
227 | ≥114 | 7
|
Words in suffix order
1 | va- | 3
|
2 | 2500g- | 2
|
3 | assessment- | 1
|
4 | 15. | 1
|
5 | 51.00 | 2
|
6 | 13.3/1000 | 1
|
7 | 4.3/1000 | 2
|
8 | 3.5/1000 | 1
|
9 | 9.5/1000 | 2
|
10 | 20:1000 | 2
|
11 | 1:1000 | 30
|
12 | 50.01-100 | 1
|
13 | 99.5-100 | 1
|
14 | 87.6-100 | 1
|
15 | 60/100 | 8
|
16 | microl/100 | 1
|
17 | 60-600 | 2
|
18 | 94+/-10 | 1
|
19 | iii-30:10 | 1
|
20 | c=10 | 1
|
21 | ii-20:20 | 1
|
22 | t20 | 25
|
23 | 93-1,140 | 1
|
24 | 14-60 | 2
|
25 | e70 | 5
|
26 | 51.31±15.80 | 1
|
27 | 29-90 | 1
|
28 | 1 | 133,836
|
29 | 44,1 | 1
|
30 | 45,1 | 1
|
31 | 67,1 | 1
|
32 | 7-1 | 2
|
33 | days-1 | 2
|
34 | 3x/day-1 | 1
|
35 | 22±2.1 | 1
|
36 | 4.8-5.1 | 3
|
37 | b-87.1 | 1
|
38 | 4.6±18.1 | 1
|
39 | 1a=201 | 1
|
40 | b=66.51 | 1
|
41 | compliance=71 | 1
|
42 | 166/91 | 1
|
43 | 2=91 | 1
|
44 | 1=1 | 1
|
45 | 2=1 | 2
|
46 | ln1 | 6
|
47 | cpr1 | 1
|
48 | ~1 | 58
|
49 | ≈1 | 13
|
50 | age≥1 | 1
|
51 | ±1 | 39
|
52 | iii-2 | 1
|
53 | rm-2 | 2
|
54 | /=0.2 | 2
|
55 | drug-11.2 | 1
|
56 | 3.5-3.2 | 1
|
57 | 3.5±3.2 | 1
|
58 | a-85.2 | 1
|
59 | 2.9~6.2 | 2
|
60 | 361.5±8.2 | 1
|
61 | 30-day,6-12 | 1
|
62 | baseline-12 | 1
|
63 | 3x12 | 1
|
64 | 3:22 | 1
|
65 | 1=92 | 1
|
66 | gbp2 | 2
|
67 | 32,3 | 1
|
68 | 117+/-3 | 1
|
69 | 2-1-5-3 | 1
|
70 | cr-3 | 2
|
71 | iv-75.3 | 1
|
72 | 003 | 13
|
73 | 20050203 | 4
|
74 | 11,2013 | 1
|
75 | a-1.23 | 1
|
76 | 7,33 | 1
|
77 | 0.55-0.63 | 1
|
78 | 73-83 | 2
|
79 | pcup3 | 3
|
80 | 1:82.4 | 1
|
81 | c-75.4 | 1
|
82 | k=9.4 | 1
|
83 | 1/4 | 152
|
84 | ≥114 | 7
|
85 | 34±14 | 3
|
86 | 1/24 | 3
|
87 | m2-124 | 6
|
88 | +/-0,64 | 1
|
89 | 2–4 | 3
|
90 | 12.7±4 | 1
|
91 | a-5 | 3
|
92 | 3-83.5 | 1
|
93 | 4.0-5.5 | 3
|
94 | age=23.7±5.5 | 1
|
95 | -0.205 | 4
|
96 | a,15 | 1
|
97 | l15 | 3
|
98 | 266+/-25 | 1
|
99 | 8025 | 1
|
100 | 0·725 | 3
|
101 | a-35 | 1
|
102 | d-35 | 1
|
103 | 0.38-0.45 | 1
|
104 | 130-145 | 1
|
105 | and∼65 | 1
|
106 | 8-75 | 2
|
107 | a-75 | 2
|
108 | gpc5 | 1
|
109 | 106,6 | 1
|
110 | 9,6 | 1
|
111 | 171±116 | 1
|
112 | 261+/-36 | 1
|
113 | -1.91+/-0.36 | 1
|
114 | 48,946 | 1
|
115 | 0.90-0.96 | 3
|
116 | 45.96 | 1
|
117 | 1988-1996 | 2
|
118 | a=6 | 1
|
119 | b=6 | 1
|
120 | ri-7 | 2
|
121 | difference=8.7 | 1
|
122 | 4:17 | 1
|
123 | 5-747 | 1
|
124 | 53.83±6.57 | 1
|
125 | 7157 | 2
|
126 | 161-167 | 1
|
127 | 3587 | 4
|
128 | 1979-1987 | 2
|
129 | 9,8 | 1
|
130 | 2.4±0.8 | 2
|
131 | sevo1.8 | 4
|
132 | 2.0±1.8 | 2
|
133 | 2.4-4.8 | 4
|
134 | 2056.8 | 1
|
135 | 0.11±0.008 | 2
|
136 | 7788/18 | 1
|
137 | 27,418 | 2
|
138 | r18 | 5
|
139 | 58.28 | 2
|
140 | p=0.258 | 3
|
141 | 1981-1998 | 2
|
142 | cals8 | 2
|
143 | 6.2-10.9 | 1
|
144 | 8.6-10.9 | 1
|
145 | 91.4+/-21.9 | 1
|
146 | 4.5±1.9 | 2
|
147 | iv-84.9 | 1
|
148 | 37.3±4.9 | 1
|
149 | 205.9 | 2
|
150 | a=68.9 | 1
|
151 | -10.319 | 1
|
152 | 6/479 | 2
|
153 | g1359a | 3
|
154 | terricola | 1
|
155 | r-china | 1
|
156 | reclinata | 1
|
157 | invasiva | 1
|
158 | 1'c | 1
|
159 | edic | 66
|
160 | 50-60°c | 3
|
161 | -2d | 4
|
162 | 12d | 13
|
163 | 1.6/restricted | 1
|
164 | 1966-3rd | 1
|
165 | caesalpinioideae | 2
|
166 | dcbe | 2
|
167 | school-entrance | 2
|
168 | eur/life | 1
|
169 | hike | 8
|
170 | myrenne | 1
|
171 | 1minute | 7
|
172 | pubs-positive | 1
|
173 | ≤half | 1
|
174 | pdi/bpdrf | 1
|
175 | rcwmch | 3
|
176 | 12-th | 1
|
177 | 210th | 3
|
178 | 11th-14th | 1
|
179 | 19th-24th | 1
|
180 | /=4th | 1
|
181 | 1/8th | 1
|
182 | al-i | 3
|
183 | ca-cdi | 2
|
184 | ecj | 3
|
185 | 11u/l | 1
|
186 | 1l | 23
|
187 | 0.237×gestational | 1
|
188 | tyrrell | 1
|
189 | 200ml | 10
|
190 | r2-m | 5
|
191 | it-m | 4
|
192 | adm/bdm | 1
|
193 | inditherm | 1
|
194 | 0.5μm | 3
|
195 | 1-3min | 2
|
196 | 0=ovulation | 1
|
197 | cost-assumption | 1
|
198 | querco | 1
|
199 | pio-mono | 4
|
200 | bbop | 2
|
201 | fbtp | 4
|
202 | 7-par | 3
|
203 | vicr | 2
|
204 | two-four | 1
|
205 | dapis | 2
|
206 | hardjo-bovis | 3
|
207 | βmaks | 2
|
208 | 48-weeks | 3
|
209 | 16-years | 2
|
210 | 1tss | 1
|
211 | 6-halts | 6
|
212 | 5/vs | 1
|
213 | 5.5days | 2
|
214 | pi-treatment | 3
|
215 | 0=treatment | 1
|
216 | month-test | 1
|
217 | 400iu | 2
|
218 | dansyl-sstsaa-w | 2
|
219 | five/six | 1
|
220 | 40-tx | 2
|
221 | 3-tx | 1
|
222 | 0.5mg/kg/day | 4
|
223 | 800mg/day | 6
|
224 | ii-insufficiency | 1
|
225 | breaks/sedentary | 1
|
226 | leone® | 3
|
227 | micerium® | 1
|